chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my vaccine in my right arm around 3:20 pm on 1/5/21. My right arm started getting sore later that evening. The following day, 1/6/21, my arm was very sore and the injection site was tender to touch. I felt feverish and had chills. I also had a headache and felt very fatigued. I took some Advil that morning. I evaluated my arm in the evening and noticed a large red rash streaking down my right arm from the injection site. It measured approximately 3.5 in X 1.5 in. The rash was red, raised, painful, and firmer than my surrounding skin. I took 500 mg of Tylenol before bed. The next morning, 1/7/21, the rash had grown larger. The border of the rash was marked and I took an antihistamine around 7:00 am. At 1:00 pm the rash had grown larger, now measuring approximately 4.25 in X 2.25 in. My lymph nodes in my right armpit were also beginning to get sore. I visited the nurse practitioner at my hospital?s employee health clinic around 1:40 pm and we agreed to monitor my signs and symptoms at that time. The following morning, 1/8/21, the rash was bigger, but my skin was softer and more of a pink color than red. My arm did not hurt as much, though my right armpit was slightly more sore. Today, 1/9/21, my symptoms are much better. I have only slight soreness in my right arm and armpit. My rash has nearly resolved, though it is slightly itchy where the rash was.
Fully vaccinated and boosted 11/17/21.   Symptomatic COVID infection breakthrough with inpatient hospital stay to ICU.  Immunosuppressed
1 day p/vax pt devel an inj site rxn characterized by a 2-inch area of erythema, swelling, & pain;this is 1 of 2 pt from site to devel an inj site rxn p/Td lot# 438594;
Td was given intradermally as PPD by mistake.  Left forearm red and 8mm induration.  Patient complained of itching.  No other complications.  Followup received on 03/16/2005:  Patient recovered.  Patient did not make a follow up visit for Td injection.  Patient went to the primary doctor to get chest X-rays for the PPD.
Has had High Blood Pressure and high cholesterol in the past, as well as testing positive for Diabetes II.  I had it under control  then I was diagnosed with Prostate Cancer and had surgery one week after 1st COVID-19 vaccination. Ever since then my blood pressure and cholesterol have been rising, my Dr. has started to monitoring it and prescribed Amlodipene for my High Blood Pressure.
Myalgia Narrative:  I got Covid vaccine #2 yesterday and today I woke up with body aches and skin sensitivity
Full body hives, severe itching, large dry scaly patches of red skin. Swelling of finger joints. Skin breaks. Painful. Treated with OTC medications, lotions, benadryl,  mometasone fur cream; nothing helps. Started with this condition in late October 2021; it is now February 1, 2022 and I still have these issues.
Metal taste in tongue within 5 minutes of receiving vaccine. Swelling of left side of tongue within 25 minutes of receiving vaccine.   Had already left clinic. Took 2 Benedryl capsules.  Swelling stopped within 20 min.
Diarrhea, urgency,  bloating, gas, mild pain after meals, pissing out of my ass for over a month.  It is still occurring, but I have it more under control by only eating beans and rice.  I'm on a strict healing diet. It is helping, but I'm not better and it has almost been 2 months.  I had to pay to see a naturopath that I wouldn't have had to do if I didn't get the vaccine.
Pt got Dtap 10/24/06 in R T. Pt c/o redness and swelling to right anterior thigh on 10/25/06. Redness 15x9cm.
Fever 104F and hallucinations prompting ED visit. While in CT, rigors observed which raised concern for seizure. Patient was admitted for workup. Subsequent EEG did not reveal epileptiform activity.
MMR, VAR, TDAP given 12-1-10 - a.m. Rash developed 12-3-10 around 11:00 a.m. Clt. ate eggs 12-3-10 at 9:00 a.m. Has had rash previously after eating eggs & suspected allergy.
COULD NOT SEE; MATERNAL EXPOSURE DURING PREGNANCY; COULD NOT BREATHE; DIZZINESS; FEELING UNWELL; MUSCLE PAIN; This solicited pregnancy report received from a consumer concerned a 38 year old female of unknown race and ethnicity. The patient was enrolled in a non-company sponsored study.  The patient's height, and weight were not reported. The patient's past medical history included: miscarriage (one), and concurrent conditions included: multigravida (four previous pregnancies, three resulting in a live baby).  The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A expiry: UNKNOWN) dose was not reported, 1 total was administered on 12-OCT-2021 for covid-19 immunisation. No concomitant medications were reported. The first day of the last menstrual period (LMP) was calculated to be 06-Mar-2021. The estimated delivery date (EDD) was reported to be 11-Dec-2021. Type of pregnancy was not reported. On 12-Oct-2021 (at the time of vaccination), patient was at gestational age of 31 weeks and three days. On 12-OCT-2021, the patient experienced maternal exposure during pregnancy, muscle pain, dizziness, was feeling unwell and could not see or breathe. All reported events led to emergency room and subsequently hospital admission. The patient received intravenous infusion and medical attention. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not see, could not breathe, dizziness, feeling unwell, and muscle pain on 13-OCT-2021, and the outcome of maternal exposure during pregnancy was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and maternal exposure during pregnancy was not related, and between covid-19 vaccine ad26.cov2.s, and could not see, could not breathe, dizziness, feeling unwell, and muscle pain was related.  This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20211118554-COVID-19 VACCINE AD26.COV2.S- Could not see, Could not breathe, Dizziness. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211118554-COVID-19 VACCINE AD26.COV2.S-Maternal exposure during pregnancy. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS 20211118554-COVID-19 VACCINE AD26.COV2.S- Feeling unwell, Muscle pain. This event(s) is labeled per RSI and is therefore considered potentially related.
At approximately 10:30pm on 1/14/2021, resident was noted to have a rash on her face, hands, arms, and chest. VS:100.2, 113, 20,108/59, 84% room air. applied nasal cannula at 4-L, telephoned Physician orders 6mg Decadron one time order, a second set of Vitals , reads 99.3, 110, 20, 106/60, 90% on 4-L N/C. On coming shift advised. At approximately 2:00am on 1/15/2021, resident congested and coughing. BP 151/70, pulse 124, temp 98.1 forehead, resp 20 and pulse oc 79% on 3L. At approximately 2:30am PRN cough syrup and breathing tx. Resident's condition began to worsen with breathing tx. This LPN updated at 0248 doctor on resident's condition. Doctor gave permission for resident to go to hospital. At 4:19am the Er called to say resident passed away.
started 1-2 hr p/vax started shaking broke out in a cold sweat; had a deep cry that would cont until mom would hold pt-cont into the noc; 2 hr p/vax temp now 101; temp ran 105 x 2 days w/constantly given APAP; ear infect
INCORRECT PRODUCT STORAGE; POOR QUALITY DRUG ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and batch number: 206A21A expiry: 23-JUN-2021) dose was not reported, administered on 19-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced incorrect product storage, and poor quality drug administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect product storage and poor quality drug administered was not reported. This report was non-serious.
22mo old vaccinated 8-JAN-90, 13 days later 22-JAN-90 marked flushing, sweating on rt side of body w/lt side pale.  Unusual behavior & grabbed at his mouth. Symptoms like "Harlequin synd seen in NB.Also autonomic dysfunction; lasted 2 days.
Red, swollen rash on left arm below the injection site.  Area was very hot and itchy. Unpleasant and painful when touched
Have covid infection 6/2022. Shortly after severe abdominal pain,  then infection then worked up and diagnosed with mets to liver colon cancer
Inappropriate schedule of vaccine administered; Migraine; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), VACCINATION SITE PAIN (Vaccination site pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   On 27-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 11-Nov-2021, the patient experienced MIGRAINE (Migraine). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). The patient was treated with GABAPENTIN at an unspecified dose and frequency and KETOROLAC at an unspecified dose and frequency. In 2021, VACCINATION SITE PAIN (Vaccination site pain) had resolved. In November 2021, MIGRAINE (Migraine) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.     Concomitant product use was not provided by the reporter.  In 2021, the patient experienced sore was with all Covid-19 vaccine.  On 11-Nov-2021, the patient experienced migraine.  In Nov-2021, the migraine resolved.  In 2021, the sore was with all Covid-19 vaccine and migraine resolved.  It was unknown if patient was enrolled in a Covid-19 Vaccine Trial.  Causality for Humira (Adalimumab) for the event of sore were with all covid-19 vaccine with Humira (Adalimumab) was no reasonable possibility.  The reporter's causality for the event of migraine onset 11-Nov-2021 was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-625684 (Patient Link).
PT WAS DX WITH KAWASAKI DISEASE AFTER THE VACCINATION. 12/2/09 ER records received for date 11/8/09 and ER visit 11/9/09. DX: Kawasaki Presents w/ c/o of fever 102F s/p neck abscess x3 days. Assessment: 2nd presentation of neck abscess vs. lymphadenitis, fever, cough, tx in ER for UTI. Suspected for Kawasaki, (+)swelling hands, scrotum, rash on trunk, abdominal distention. ER rec for 11/9/09 increase in fever, and worsening of SX. Assessment: (+)strawberry tongue, injected conjuntivitis. Pt admitted.
Patient stated she had issues in the past with passing out from vaccines. She said she did fine with the first 2 doses of the COVID-19 Pfizer vaccine. After vaccination, patient was lightheaded so we had her remain seated. She took a sip of water from her bottle and was breathing in and out to calm herself. After a few minutes, patient's eyes closed and she fainted in the seat. I was able to get to the patient and hold her. We called for emergency services to come in and evaluate her. I remained with patient until they arrived. They evaluated her and deemed her ok to go home. Patient was able to walk out on her own after being evaluated.
Patient received Moderna bivalent booster dose that had undergone a temperature excursion.; Patient received Moderna bivalent booster dose that had undergone a temperature excursion.; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.) and NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna bivalent booster dose that had undergone a temperature excursion.).    No concomitant medications were reported.  The case was reported for 72th out of 77 adult patients who had received the vaccine as reported by the reporter.  It was reported that the vaccine was administered approximately to 77 patients before it was known if the vaccine was ok to use after the excursion.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-696122 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-696122:Master case
I had a more serious reaction, but different symptoms, only to my first shot.; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (I had a more serious reaction, but different symptoms, only to my first shot.) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (I had a more serious reaction, but different symptoms, only to my first shot.). At the time of the report, IMMUNISATION REACTION (I had a more serious reaction, but different symptoms, only to my first shot.) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       Concomitant medication list was not provided. The patient reported that patient had a more serious reaction, but different symptoms, only to the first shot. The other shots were tolerated with no side effects. Treatment information was not provided.   This case was linked to MOD-2022-663877 (Patient Link).
Large area of redness, pain, warmth at site 20 cm x 10 cm, fever 104, vomiting, diarrhea, decreased platelets to 30k.
Bad reaction to vaccine; Following each vaccine I have felt worse than the one before; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD-2022-629305 (Moderna Vaccine Events).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Oct2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "had Covid", start date: Oct2020 (unspecified if ongoing), notes: Oct20,lost son aged yrs to Hsptl Acquired Covid.this month caught Covid from my son when visit Hsptl. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine astrazeneca (DOSE 1, SINGLE), administration date: Jan2021, for Covid-19 Immunization; Covid-19 vaccine astrazeneca (DOSE 2, SINGLE), administration date: Apr2021, for Covid-19 Immunization.  The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Bad reaction to vaccine"; MALAISE (non-serious), outcome "unknown", described as "Following each vaccine I have felt worse than the one before".  Additional information: In Oct2020 I lost my son aged years to hospital acquired Covid. Also in this month I had Covid which I caught from my son when visiting him in hospital. In Jan2021 I received my 1st dose of (Manufacturer Name withheld) followed in April 2021 by the 2nd dose of (Manufacturer Name withheld). In Oct2021 I had a booster vaccine of Pfizer. In May2022 I had a booster of Moderna. My question is what is the same ingredient in all of these vaccines that make me so ill? following each vaccine I have felt worse than the one before. When I had the last vaccine Moderna I felt that ill that I don't think I will be having any more. I was delirious, replying to questions asked with totally irrelevant answers, when I came to I could not move my legs it was as though I was paralyzed for a good 2 or 3 minutes it was really scary. I also had the most awful headache and vomiting and was bed ridden for nearly a week. I wasn't as bad when I had actual Covid. I really don't think at I can go through this again when each dose is worse than the one before can you throw any light onto why this happens. Other people just seem to have a sore arm.   No follow-up attempts are possible. No further information is expected.
Pt received vaccines on 10/25/00 and on 10/26/00, infant asleep with 16 year old sibling. Mother found arm of sibling across baby's face and baby was not breathing. CPR was administered and intubation to no avail. Autopsy shows found unresponsive, congestion of lungs, kidneys congested. Final cause of death stated as suffocation by mechanical asphyxia.
This case was reported by a healthcare professional and described the occurrence of possible HEPATITIS B in an elderly female subject who was vaccinated with ENGERIX B, (GlaxoSmithKline).  Concurrent medical conditions included dialysis, hypertension and renal failure.  Concurrent medications included alot of unknown concurrent medications.  In March 2007 the subject received unspecified dose of ENGERIX B (1 cc, unknown).  At an unspecified time after vaccination with ENGERIX B, the subject had lab work that "looks like an elderly female had HEP B disease."  The nurse questioned transient antigenemia.  At the time of reporting the outcome of the events were unspecified.  Follow-up information received on 20 May 2008 indicated that the subject was 78 years of age at the time of event.  The events resolved on an unspecified date.  A HEPATITIS B surface antigen test performed on 08 April 2008 was positive.  A repeat test performed on 15 April 2008 was negative.  The reporter suggested that the first test was a possible false positive due to receiving the vaccine a few days prior to the lab draw.  According to follow-up, the subject started dialysis on 16 May 2007 and it is continuing.  The subject has a concurrent medical condition of renal failure and a medical history of hypertension.  It was reported that the subject had the complete 1st series of 4 hepatitis B injections.
This spontaneous report as received from a nurse refers to a female patient of unknown age. No information regarding the patient's medical history was provided. On an unknown date, reported as about 6 years ago, the patient was vaccinated with GARDASIL dose 1 and 2. Route was not reported. No concomitant medication was reported. On 18-DEC-2013 the patient was in the office to possibly get her third dose. No adverse effects were reported. No outcome was reported. Additional information has been requested.
Nausea, body aches, chills, fever.  Two weeks later, hair loss started (still happening) and significant right thumb and palmar swelling.
Moving severe joint pain. Has been occurring almost daily and requiring ibuprofen to reduce pain. It moves to a new site every couple days, seems random or occasionally if that area is overworked.
Patient is 13yoa and was administered the Janssen vaccine instead of Pfizer. Reporting due to patient age. Per mom no adverse effects have been experienced at this time.
mislabled the product as having an expiraiton date of 11/31/23 instead of 1/30/23.; Expired Havrix administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a adult male patient who received HAV (Havrix) (batch number unknown, expiry date 31st January 2023) for prophylaxis.   On 20th February 2023, the patient received the 1st dose of Havrix. On 20th February 2023, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the patient experienced product label confusion. On an unknown date, the outcome of the expired vaccine used and product label confusion were unknown.   Additional Information: GSK receipt date: 21-FEB-2023 Reporter comment: The pharmacist reports a dose of Havrix was administered to a male patient on 20th February 2023, and then realized the expiration date was 31st Januray 2023.   The pharmacist stated someone from the facility had mislabled the product as having an expiraiton date of 31st January 2023 instead of 30th January 2023.   This was the patients first dose in the series.   At the time of reporting, the pharmacist did not have the lot number of the dose.   The pharmacist states the patient is in his 50's but did not have an exact age or date of birth.   The pharmacist did not have the patient's initials at the time of the call.   At the time of reporting, the dose has not been repeated. The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Havrix vaccine which led to expired vaccine used and mislabled the product as having an expiraiton date of 31st January 2023 instead of 30th January 2023, which led to  product label confusion.
Woke up on Monday March 1 with a hard swollen shoulder (size of a tennis ball) red mark (size of a golf ball) shoulder, took a motrin, Saw my doctor on March 2, who diagnosed this as a  reaction to Covid -19 vaccination and advised use heat  This is 10 days after the vaccination.. Site is tender .Still resolving. It is now 18 hours after the first signs